{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T15:10:16Z","timestamp":1685977816633},"reference-count":59,"publisher":"EDP Sciences","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1051\/medsci\/2004205593","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T15:40:29Z","timestamp":1299339629000},"page":"593-598","source":"Crossref","is-referenced-by-count":3,"title":["\u00c9pid\u00e9mie de sida en Afrique subsaharienne"],"prefix":"10.1051","volume":"20","author":[{"given":"Xavier","family":"Anglaret","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Salamon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"250","published-online":{"date-parts":[[2004,5,15]]},"reference":[{"key":"R1","unstructured":"Onusida. Mise \u00e0 jour des donn\u00e9es \u00e9pid\u00e9miologiques sur le VIH, d\u00e9cembre 2002, 38 pages. http:\/\/www.unaids.org\/worldaidsday\/2002\/press\/update\/epiupdate2002_fr.doc"},{"key":"R2","unstructured":"Onusida. Survol de l\u2019\u00e9pid\u00e9mie dans le monde. Rapport sur l\u2019\u00e9pid\u00e9mie mondiale de VIH\/sida 2002, chapitre 2 : 21\u201342."},{"key":"R3","unstructured":"Onusida. Rapport sur l\u2019\u00e9pid\u00e9mie mondiale de VIH\/sida 2002. 214 pages.http:\/\/www.unaids.org\/barcelona\/presskit\/french\/barcelonareport\/contents_html.html"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Buv\u00e9 A, Bishikwabo-Nsarhaza K, Mutangadura G. The spread and effect of HIV-1 infection in sub-Saharan Africa.Lancet2002; 359 : 2001\u201317.","DOI":"10.1016\/S0140-6736(02)08823-2"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Zhu T, Korber B, Nahmias A,et al.An African HIV-1 sequence from 1959 and implications for the origin of the epidemic.Nature1998; 391 : 594\u20137.","DOI":"10.1038\/35400"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Korber B, Muldoon M, Theiler J,et al.Timing the ancestor of the HIV-1 pandemic strains.Science2000; 288 : 1789\u201396.","DOI":"10.1126\/science.288.5472.1789"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Quinn T. Global burden of the HIV pandemic.Lancet1996; 348 : 99\u2013106.","DOI":"10.1016\/S0140-6736(96)01029-X"},{"key":"R8","unstructured":"Peeters M, Sharp P. Genetic diversity of HIV-1 : The moving target.AIDS2000; 14 : 129\u201340."},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Buv\u00e9 A, Cara\u00ebl M, Hayes R,et al.The multicentre study on factors determining the differential spread of HIV in four African cities : Summary and conclusions.AIDS2001; 15 : 127\u201331.","DOI":"10.1097\/00002030-200108004-00014"},{"key":"R10","unstructured":"Banque mondiale. Rapport sur le d\u00e9veloppement dans le monde 1993 : investir dans la sant\u00e9. Paris, 1993, 340 p."},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Djomand G, Greenberg AE, Sassan-Morokro M,et al.The epidemic of HIV\/AIDS in Abidjan, C\u00f4te d\u2019Ivoire : A review of data collected by projet RETRO-CI from 1987 to 1993.J Acquir Immune Def Syndr Hum Retrovir1995; 10 : 358\u201365.","DOI":"10.1097\/00042560-199511000-00008"},{"key":"R12","unstructured":"Anglaret X, Gnangbomon J, Coulibaly-Kon\u00e9 S,et al.Clinical and immunological stages of HIV-infected patients attending community clinics, Abidjan, C\u00f4te d\u2019Ivoire.Int JSTD AIDS1998; 9 : 432\u20133."},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Grant A, Djomand G, Smets P,et al.Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, C\u00f4te d\u2019Ivoire.AIDS1997; 11 : 1357\u201364.","DOI":"10.1097\/00002030-199711000-00010"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Kamanfu G, Mlika-Cabanne N, Girard P,et al.Pulmonary complications of human immunodeficiency virus infection in Bujumbura, Burundi.Am Rev Respir Dis1993; 147 : 658\u201363.","DOI":"10.1164\/ajrccm\/147.3.658"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Brindle RJ, Nunn PP, Batchelor BI,et al.Infection and morbidity in patients with tuberculosis in Nairobi, Kenya.AIDS1993; 7 : 1469\u201374.","DOI":"10.1097\/00002030-199311000-00010"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Clerinx J, Bogaerts J, Taelman H,et al.Chronic diarrhoea among adults in Kigali, Rwanda : association with bacterial enteropathogens, rectocolonic inflammation, and human immunodeficiency virus infection.Clin Infect Dis1995; 21 : 1282\u20134.","DOI":"10.1093\/clinids\/21.5.1282"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Malin A, Gwanzura L, Klein S,et al.Pneumocystis cariniipneumonia in Zimbabwe. Lancet 1995; 346 : 1258\u201361.","DOI":"10.1016\/S0140-6736(95)91862-0"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Daley C, Mugusi F, Chen L,et al.Pulmonary complications of HIV infection in Dar es Salaam, Tanzania. Role of bronchoscopy and bronchoalveolar lavage.Am J RespirCrit Care Med1996; 154 : 105\u201310.","DOI":"10.1164\/ajrccm.154.1.8680664"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Jones N, Huebner R, Khoosal M,et al.The impact of HIV onStreptococcus pneumoniae bacteraemiain a South African population.AIDS1998; 12 : 2177\u201384.","DOI":"10.1097\/00002030-199816000-00013"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Archibald L, McDonald L, Nwanyanwu O,et al.A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi : implications for diagnosis and therapy.J Infect Dis2000; 181 : 1414\u201320.","DOI":"10.1086\/315367"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Batungwanayo J, Taelman H, Allen S,et al.Pleural effusion, tuberculosis and HIV-1 infection in Kigali, Rwanda.AIDS1993; 7 : 73\u20139.","DOI":"10.1097\/00002030-199301000-00011"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Batungwanayo J, Taelman H, Lucas S,et al.Pulmonary disease associated with the human immunodeficiency virus in Kigali, Rwanda : a fibre optic bronchoscopic study of 111 cases of undetermined etiology.Am J Respir Crit Care Med1994; 6 : 1591\u20136.","DOI":"10.1164\/ajrccm.149.6.8004318"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Gilks C, Brindle R, Otieno L,et al.Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya.Lancet1990; 346 : 545\u20139.","DOI":"10.1016\/0140-6736(90)92096-Z"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Scott J, Hall A, Muyodi C,et al.Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya.Lancet2000; 355 : 1225\u201330.","DOI":"10.1016\/S0140-6736(00)02089-4"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Vugia DJ, Kiehlbauch JA, Yeboue K,et al.Pathogens and predictors of fatal septicemia associated with the human immunodeficiency virus infection in Ivory Coast, West Africa.J Infect Dis1993; 168 : 564\u201370.","DOI":"10.1093\/infdis\/168.3.564"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Mwachari C, Batchelor B, Paul J,et al.Chronic diarrhoea among HIV-infected adult patients in Nairobi, Kenya.J Infect1998; 37 : 48\u201353.","DOI":"10.1016\/S0163-4453(98)90561-8"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Germani Y, Minssart P, Vohito M,et al.Etiologies of acute, persistent, and dysenteric diarrheas in adults in Bangui, Central African republic, in relation to human immunodeficiency virus serostatus.Am J Trop Med Hyg1998; 59 : 1008\u201314.","DOI":"10.4269\/ajtmh.1998.59.1008"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Lucas SB, Hounnou A, Peacock C,et al.The mortality and pathology of HIV infection in a West African city.AIDS1993; 7 : 1569\u201379.","DOI":"10.1097\/00002030-199312000-00005"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Leroy V, Msellati P, Lepage P,et al.Natural history of HIV-1 infection in African women : a prospective cohort study in Kigali, Rwanda, 1988-1993.J Acquir Immune Def Syndr1995; 9 : 415\u201321.","DOI":"10.1097\/00042560-199508000-00013"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Gilks C, Ojoo S, Brindle R,et al.Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya.Lancet1996; 347 : 718\u201323.","DOI":"10.1016\/S0140-6736(96)90076-8"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"French N, Nakiyingi J, Carpenter L,et al.23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults : double-blind, randomised and placebo controlled trial.Lancet2000; 355 : 2106\u201311.","DOI":"10.1016\/S0140-6736(00)02377-1"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Perri\u00ebns JH, St Louis ME, Mukadi YB,et al.Pulmonary tuberculosis in HIV-infected patients in Za\u00efre. A controlled trial of treatment for either 6 or 12 months.N Engl J Med1995; 332 : 779\u201384.","DOI":"10.1056\/NEJM199503233321204"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Allen S, Batungwanayo J, Kerlikowske K,et al.Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women.Am J Med1992; 146 : 1439\u201344.","DOI":"10.1164\/ajrccm\/146.6.1439"},{"key":"R34","doi-asserted-by":"crossref","unstructured":"Ackah AN, Coulibaly D, Digbeu H,et al.Response to treatment, mortality, and CD4 lymphocytes counts in HIV-infected persons with tuberculosis in Abidjan, C\u00f4te d\u2019Ivoire.Lancet1995; 345 : 607\u201310.","DOI":"10.1016\/S0140-6736(95)90519-7"},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Morgan D, Maude G, Malambra S,et al.HIV-1 disease progression and AIDS-defining disorders in rural Uganda.Lancet1997; 350 : 245\u201350.","DOI":"10.1016\/S0140-6736(97)01474-8"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"Sewankambo N, Gray R, Ahmad S,et al.Mortality associated with HIV infection in rural Rakai District, Uganda.AIDS2000; 14 : 2391\u2013400.","DOI":"10.1097\/00002030-200010200-00021"},{"key":"R37","doi-asserted-by":"crossref","unstructured":"French N, Mujugira A, Nakiyingi J,et al.Immunologic and clinical stages in HIV-1-infected Ugandan adults are comparable and provide no evidence of rapid progression but poor survival with advanced disease.J Acquir Immune Def Syndr1999; 22 : 509\u201316.","DOI":"10.1097\/00042560-199912150-00013"},{"key":"R38","doi-asserted-by":"crossref","unstructured":"Malamba S, Morgan D, Clayton T,et al.The prognostic value of the World health organisation staging system for HIV infection and disease in rural Uganda.AIDS1999; 13 : 2555\u201362.","DOI":"10.1097\/00002030-199912240-00009"},{"key":"R39","doi-asserted-by":"crossref","unstructured":"Whitworth J, Morgan D, Quigley M,et al.Effect of HIV-1 and increasing immunosppression on malaria parasitemia and clinical episodes in adults in rural Uganda.Lancet2000; 356 : 1051\u20136.","DOI":"10.1016\/S0140-6736(00)02727-6"},{"key":"R40","doi-asserted-by":"crossref","unstructured":"Anglaret X, Chene G, Attia A,et al.Early chemoprophylaxis with trimetoprim-sulphamethoxazole for HIV-1 infected adults in Abidjan, C\u00f4te d\u2019Ivoire : a randomised trial.Lancet1999; 353 : 1462\u20138.","DOI":"10.1016\/S0140-6736(98)07399-1"},{"key":"R41","doi-asserted-by":"crossref","unstructured":"Anglaret X, Messou E, Ouassa T,et al.Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis, Abidjan, C\u00f4te d\u2019Ivoire. AIDS 2003; 17 : 575\u201384.","DOI":"10.1097\/00002030-200303070-00013"},{"key":"R42","unstructured":"De Cock K, Chaisson R. Will DOTS do it ? A reappraisal of tuberculosis control in countries with high rates of HIV infection. IntJ Tuberc LungDis1999; 3 : 457\u201365."},{"key":"R43","doi-asserted-by":"crossref","unstructured":"Whalen C, Jonhson J, Okwera A,et al.A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus.N Engl J Med1997; 337 : 801\u20138.","DOI":"10.1056\/NEJM199709183371201"},{"key":"R44","unstructured":"Unaids\/WHO. Preventive therapy against tuberculosis in people living with HIV.Wkly Epidemiol Rec1999; 74 : 385\u2013400."},{"key":"R45","doi-asserted-by":"crossref","unstructured":"Quigley M, Mwinga A, Hosp M,et al.Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults.AIDS2001; 15 : 215\u201322.","DOI":"10.1097\/00002030-200101260-00011"},{"key":"R46","doi-asserted-by":"crossref","unstructured":"Fitzgerald D, Desvarieux M, Severe P,et al.Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals : a randomised trial.Lancet2000; 356 : 1470\u20134.","DOI":"10.1016\/S0140-6736(00)02870-1"},{"key":"R47","doi-asserted-by":"crossref","unstructured":"Wiktor S, Sassan-Morokro M, Grant A,et al.Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, C\u00f4te d\u2019Ivoire : a randomised controlled trial. Lancet 1999; 353 : 1469\u201375.","DOI":"10.1016\/S0140-6736(99)03465-0"},{"key":"R48","unstructured":"Unaids\/WHO. Provisional WHO\/Unaids secretariat recommendations on the use of cotrimoxazole prophylaxis in adults and children living with HIV\/AIDS in Africa. 2000 : http:\/\/www.unaids.org\/publications\/documents\/care\/general\/recommendation-eng.pdf"},{"key":"R49","unstructured":"Anglaret X, Dabis F, Batungwanayo J,et al.Chimioprophylaxie primaire de la tuberculose chez les s\u00e9ropositifs dans les pays non industrialis\u00e9s.Sant\u00e91997; 7 : 89\u201394."},{"key":"R50","doi-asserted-by":"crossref","unstructured":"Boeree M, Harries A, Zijlstra E,et al.Co-trimoxazole in HIV-1 infection.Lancet1999; 354 : 334.","DOI":"10.1016\/S0140-6736(05)75236-3"},{"key":"R51","doi-asserted-by":"crossref","unstructured":"Iyer J, Milhous W, Cortese J,et al.Plasmodium falciparumcross-resistance between trimethoprim and pyrimethamine.Lancet2001; 358 : 1066\u20137.","DOI":"10.1016\/S0140-6736(01)06201-8"},{"key":"R52","doi-asserted-by":"crossref","unstructured":"Martin J, Rose D, Hadley W,et al.Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.J Infect Dis1999; 180 : 1809\u201318.","DOI":"10.1086\/315132"},{"key":"R53","doi-asserted-by":"crossref","unstructured":"Anglaret X. Cotrimoxazole prophylaxis in sub-Saharan Africa.Lancet2001; 358 : 1027\u20138.","DOI":"10.1016\/S0140-6736(01)06227-4"},{"key":"R54","doi-asserted-by":"crossref","unstructured":"Weidle P, Malamba S, Mwebaze R,et al.Assessment of a pilot antiretroviral drug therapy programme in Uganda : patients\u2019 response, survival, and drug resistance.Lancet2002; 360 : 34\u201340.","DOI":"10.1016\/S0140-6736(02)09330-3"},{"key":"R55","doi-asserted-by":"crossref","unstructured":"Laurent C, Diakhate N, Gueye N,et al.The Senegalese government\u2019s highly active antiretroviral therapy initiative : an 18-month follow-up study.AIDS2002; 16 : 1363\u201370.","DOI":"10.1097\/00002030-200207050-00008"},{"key":"R56","doi-asserted-by":"crossref","unstructured":"Seyler C, Anglaret X, Dakoury-Dogbo N,et al.Medium-term survival, morbidity, and immuno-virological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, C\u00f4te d\u2019Ivoire.Antivir Ther2003; 8 : 385\u201393.","DOI":"10.1177\/135965350300800505"},{"key":"R57","doi-asserted-by":"crossref","unstructured":"Race E, Adelson-Mitty J, Kriegel G,et al.Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.Lancet1998; 351 : 252\u20135.","DOI":"10.1016\/S0140-6736(97)04352-3"},{"key":"R58","doi-asserted-by":"crossref","unstructured":"French M, Lenzo N, John M,et al.Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy.HIV Med2000; 1 : 107\u201315.","DOI":"10.1046\/j.1468-1293.2000.00012.x"},{"key":"R59","doi-asserted-by":"crossref","unstructured":"Heath K, Singer J, O\u2019Shaughnessy M,et al.Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy.J Acquir Immune Def Syndr2002; 31 : 211\u20137.","DOI":"10.1097\/00126334-200210010-00012"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2004205593\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T14:33:18Z","timestamp":1685975598000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2004205593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":59,"journal-issue":{"issue":"5"},"alternative-id":["medsci2004205p593"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2004205593","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}